CGA
ELV icon

Channing Global Advisors’s Elevance Health ELV Stock Holding History

Channing Global Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,243
Closed -$1.65M – 44
2025
Q2 		$1.65M Sell
4,243
-6,069
-59% -$2.44M 1.06% 21
2025
Q1 		$4.49M Sell
10,312
-13
-0.1% -$5.22K 3.05% 13
2024
Q4 		$3.81M Buy
10,325
+3,161
+44% +$1.32M 2.54% 15
2024
Q3 		$3.73M Buy
7,164
+3,258
+83% +$1.74M 3.14% 10
2024
Q2 		$2.12M Hold
3,906
– – 1.77% 17
2024
Q1 		$2.03M Sell
3,906
-19
-0.5% -$9.45K 1.72% 19
2023
Q4 		$1.85M Sell
3,925
-1,057
-21% -$489K 1.44% 21
2023
Q3 		$2.17M Buy
4,982
+731
+17% +$332K 2.11% 15
2023
Q2 		$1.89M Sell
4,251
-61
-1% -$28.1K 1.91% 17
2023
Q1 		$1.98M Sell
4,312
-845
-16% -$402K 2.18% 18
2022
Q4 		$2.65M Sell
5,157
-167
-3% -$84.8K 3.04% 11
2022
Q3 		$2.42M Sell
5,324
-549
-9% -$263K 3.08% 12
2022
Q2 		$2.83M Buy
5,873
+174
+3% +$86.1K 3.05% 12
2022
Q1 		$2.8M Sell
5,699
-93
-2% -$42.5K 2.71% 17
2021
Q4 		$2.69M Buy
+5,792
New +$2.44M 2.55% 18

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Channing Global Advisors's ELV Position: Q3 2025 in Review

Channing Global Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 4,243 shares — an estimated $1.65M sold.

Channing Global Advisors first reported a position in ELV in Q4 2021 and held it in 15 quarters. The position peaked at $4.49M in Q1 2025. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Channing Global Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Channing Global Advisors sold 4,243 Elevance Health shares in Q3 2025, an estimated $1.65M.
  • Channing Global Advisors first reported a position in Elevance Health in Q4 2021 and held it in 15 quarters.
  • Channing Global Advisors's Elevance Health position peaked at $4.49M in Q1 2025.
  • 1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Channing Global Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.